Open access
Open access
Powered by Google Translator Translator

Daily Archives: April 13, 2021

Cohort study: Higher cumulative exposure to Thiazide diuretics linked to an increased risk of skin cancer in people older than 65 years

13 Apr, 2021 | 05:08h | UTC

Association between antihypertensive medications and risk of skin cancer in people older than 65 years: a population-based study – Canadian Medical Association Journal

Commentaries: Thiazides May Up Risk for Skin Cancer in Older Adults – HealthDay AND Some blood pressure medication linked to higher risk of skin cancer, study finds – CTV News

Related study: Case-Control Study: Possible Association of Hydrochlorothiazide Use and Risk of Melanoma

 


AHA Scientific Statement: Management of Central Retinal Artery Occlusion

13 Apr, 2021 | 05:10h | UTC

Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association – Stroke

Commentaries: Stroke affecting the eye requires immediate treatment, can signal future vascular events – American Heart Association AND AHA Issues Statement on Central Retinal Artery Occlusion – HealthDay

 


Study: Protocoled time-limited trials among critically ill patients with advanced medical illnesses were associated with reduction of nonbeneficial ICU treatments

13 Apr, 2021 | 05:16h | UTC

Evaluation of Time-Limited Trials Among Critically Ill Patients With Advanced Medical Illnesses and Reduction of Nonbeneficial ICU Treatments – JAMA Internal Medicine (free for a limited period)

Commentary: Time-Limited Trials and Potentially Nonbeneficial Treatment in the ICU—Willing to Wait for It – JAMA Internal Medicine AND Time-limited trials may decrease the length of stay of critically ill patients in the intensive care unit – 2 Minute Medicine

Author interview: Time-Limited Trials Among Patients With Advanced Illness to Reduce Nonbeneficial ICU Treatments

Related review: Time-limited trial of intensive care treatment: an overview of current literature – Intensive Care Medicine

 


IDSA Guidance on the Treatment of ESBL Enterobacterales, Carbapenem-Resistant Enterobacterales, and Pseudomonas

13 Apr, 2021 | 05:11h | UTC

Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa) – Clinical Infectious Diseases

 


Opinion | More kids are being diagnosed with ADHD for borderline (yet challenging) behaviors. Our new research shows why that’s a worry

13 Apr, 2021 | 05:14h | UTC

More kids are being diagnosed with ADHD for borderline (yet challenging) behaviours. Our new research shows why that’s a worry – The Conversation

Original study: Overdiagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Systematic Scoping Review – JAMA Network Open

 

Commentary on Twitter

 


RCT: Inhaled budesonide shortens recovery time in non-hospitalized patients with COVID-19

13 Apr, 2021 | 05:30h | UTC

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19 – PRINCIPLE / University of Oxford

Original study (preprint): Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial – medRxiv

Commentary: Covid: Asthma drug ‘speeds up recovery at home’ – BBC

Related study: Phase 2 RCT: Inhaled budesonide shows promise for the treatment of early COVID-19 (study and commentaries)

 


Tobacco Taxes Are Most Effective Yet Least Implemented Tactics, Says WHO

13 Apr, 2021 | 05:06h | UTC

Tobacco Taxes Are Most Effective Yet Least Implemented Tactics, Says WHO – Health Policy Watch

Guidance: WHO technical manual on tobacco tax administration – World Health Organization

 


Infectivity of severe acute respiratory syndrome coronavirus 2 in children compared with adults

13 Apr, 2021 | 05:27h | UTC

Infectivity of severe acute respiratory syndrome coronavirus 2 in children compared with adults – Canadian Medical Association Journal

Commentary: Children may be less infectious in spreading SARS-CoV-2 to others – News Medical

 


Cohort Study: Effects of fluoroquinolones on outcomes of patients with aortic dissection or aneurysm

13 Apr, 2021 | 05:05h | UTC

Effects of Fluoroquinolones on Outcomes of Patients With Aortic Dissection or Aneurysm – Journal of the American College of Cardiology

Commentary: Fluoroquinolones Associated With Increased Risk of Aortic Dissection, Aneurysm – American College of Cardiology

Related: Another study suggests fluoroquinolone use may increase the risk of development of aortic aneurysms (study and commentaries) AND Link between fluoroquinolones, aorta problems may not be as strong as thought AND Study: Oral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation AND FDA Warns About Increased Risk of Aortic Dissection and Ruptures of Aortic Aneurism with Fluoroquinolones AND Meta-analysis: Fluoroquinolones and the Risk of Aortopathy AND Study: Oral Fluoroquinolone and the Risk of Aortic Dissection AND Research: Fluoroquinolone use and risk of aortic aneurysm and dissection

 


Clinical Review: Screening and management of atrial fibrillation in primary care

13 Apr, 2021 | 05:09h | UTC

Screening and management of atrial fibrillation in primary care – The BMJ

 


China considers mixing COVID-19 vaccines to boost protection rate

13 Apr, 2021 | 05:24h | UTC

China considers mixing COVID-19 vaccines to boost protection rate – Reuters

 


Cohort study: Postoperative in-hospital mortality of patients with COVID-19 infection was more than double that in patients without COVID-19

13 Apr, 2021 | 05:21h | UTC

Postoperative In-Hospital Morbidity and Mortality of Patients With COVID-19 Infection Compared With Patients Without COVID-19 Infection – JAMA Network Open

Related: Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery AND Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk

 


[Press release – not published yet] Phase 3 prevention trial showed 81% reduced risk of symptomatic SARS-CoV-2 infections with subcutaneous administration of monoclonal antibodies

13 Apr, 2021 | 05:26h | UTC

Phase 3 prevention trial showed 81% reduced risk of symptomatic SARS-CoV-2 infections with subcutaneous administration of REGEN-COV™ (Casirivimab with Imdevimab) – Regeneron

Commentaries: Regeneron says antibody cocktail prevented Covid when given as simple injection, not an IV – STAT AND Regeneron’s Covid mAb as a prophylactic injection: Reduced risk of symptomatic infection by 81% – Endpoint News

 


Perspective | They Tested Negative for Covid. Still, They Have Long Covid Symptoms.

13 Apr, 2021 | 05:23h | UTC

They Tested Negative for Covid. Still, They Have Long Covid Symptoms. – Kaiser Health News

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.